01 1Archimica S.p.A.
02 1DARMERICA, LLC
03 1Fagron Inc
04 1Genvion Corporation
05 1Medisca Inc.
06 1OLON ACTIVE PHARMACEUTICAL INGREDIENTS INDIA PRIVATE LIMITED
07 2Olon SpA
08 1Professional Compounding Centers of America dba PCCA
09 1Shandong Anxin Pharmaceutical Co., Ltd.
10 1Spectrum Laboratory Products, Inc.
01 3HYDROXYUREA
02 8Hydroxyurea
01 1Canada
02 4Italy
03 1Netherlands
04 3U.S.A
05 2United Kingdom
NDC Package Code : 55512-0003
Start Marketing Date : 2009-09-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-323
Start Marketing Date : 2020-08-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (500g/500g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-0851
Start Marketing Date : 2004-09-01
End Marketing Date : 2026-01-13
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 62049-135
Start Marketing Date : 2013-03-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-1354
Start Marketing Date : 2013-03-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0022
Start Marketing Date : 2012-12-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0023
Start Marketing Date : 2012-12-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0072
Start Marketing Date : 2020-01-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 35369-0006
Start Marketing Date : 2019-04-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-3650
Start Marketing Date : 1999-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
13
PharmaCompass offers a list of Hydroxyurea API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hydroxyurea manufacturer or Hydroxyurea supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hydroxyurea manufacturer or Hydroxyurea supplier.
PharmaCompass also assists you with knowing the Hydroxyurea API Price utilized in the formulation of products. Hydroxyurea API Price is not always fixed or binding as the Hydroxyurea Price is obtained through a variety of data sources. The Hydroxyurea Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Hydroxyurea manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hydroxyurea, including repackagers and relabelers. The FDA regulates Hydroxyurea manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hydroxyurea API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hydroxyurea manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hydroxyurea supplier is an individual or a company that provides Hydroxyurea active pharmaceutical ingredient (API) or Hydroxyurea finished formulations upon request. The Hydroxyurea suppliers may include Hydroxyurea API manufacturers, exporters, distributors and traders.
click here to find a list of Hydroxyurea suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Hydroxyurea as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Hydroxyurea API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Hydroxyurea as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Hydroxyurea and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Hydroxyurea NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Hydroxyurea suppliers with NDC on PharmaCompass.
We have 9 companies offering Hydroxyurea
Get in contact with the supplier of your choice:
